Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
2012 ◽
Vol 56
(3)
◽
pp. 250-261
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 90
(6)
◽
pp. 957-963
◽
2017 ◽
Vol 36
(6)
◽
pp. 383-389
◽